PGR and breast cancer: At the molecular level, BC is mainly classified as hormone receptor-positive (HR+), according to the expression of estrogen receptor (ER) and progesterone receptors (PRs), and/or human epidermal growth factor receptor 2-positive (HER2+; HER2/ERBB2), if HER2 oncogene is amplified.